Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress-Reference-Cited by-同舟云学术

Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress

Published:2014-11-02 Issue:12 Volume:20 Page:1417-1426
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Hasnain Sumaira Z,Borg Danielle J,Harcourt Brooke E,Tong Hui,Sheng Yonghua H,Ng Choa Ping,Das Indrajit,Wang Ran,Chen Alice C-H,Loudovaris Thomas,Kay Thomas W,Thomas Helen E,Whitehead Jonathan P,Forbes Josephine M,Prins Johannes B,McGuckin Michael A

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.3705.pdf

Reference67 articles.

1. Ashcroft, F.M. & Rorsman, P. Diabetes mellitus and the beta cell: the last ten years. Cell 148, 1160–1171 (2012).

2. Back, S.H. & Kaufman, R.J. Endoplasmic reticulum stress and type 2 diabetes. Annu. Rev. Biochem. 81, 767–793 (2012).

3. Cnop, M., Foufelle, F. & Velloso, L.A. Endoplasmic reticulum stress, obesity and diabetes. Trends Mol. Med. 18, 59–68 (2012).

4. Donath, M.Y. & Shoelson, S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98–107 (2011).

5. Volchuk, A. & Ron, D. The endoplasmic reticulum stress response in the pancreatic beta-cell. Diabetes Obes. Metab. 12 (suppl. 2), 48–57 (2010).

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probiotics intervention for type 2 diabetes mellitus therapy: a review from proposed mechanisms to future prospects;Critical Reviews in Food Science and Nutrition;2024-08-08

2. Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges;Frontiers in Pharmacology;2024-08-06

3. Lipid-encapsulated mRNA encoding an extended serum half-life interleukin-22 ameliorates metabolic disease in mice;Molecular Metabolism;2024-08

4. Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis;Nature Communications;2024-05-29

5. Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis;Nature Communications;2024-05-29